Page last updated: 2024-09-05

sb 203580 and Proteinuria

sb 203580 has been researched along with Proteinuria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, H; Jiang, D; Jin, N; Wang, Q; Zhang, X; Zhu, K	1

Other Studies

1 other study(ies) available for sb 203580 and Proteinuria

Article	Year
The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus. International immunopharmacology, 2011, Volume: 11, Issue:9 Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Complement C3; Creatinine; Female; Hepatocytes; Imidazoles; Immunoglobulins; Kidney; Kidney Diseases; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proteinuria; Pyridines; Spleen	2011

Article

Year

The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus.

International immunopharmacology, 2011, Volume: 11, Issue:9

Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Complement C3; Creatinine; Female; Hepatocytes; Imidazoles; Immunoglobulins; Kidney; Kidney Diseases; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Proteinuria; Pyridines; Spleen

2011